SELECT Trial: Advances in Semaglutide Cardiovascular Findings
Table of Contents Introduction The field of cardiovascular medicine is undergoing significant transformation, driven by pioneering research and novel therapies. Leading this change is the SELECT (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity) Trial. This pivotal study investigates the cardiovascular benefits of Semaglutide, a drug primarily used for diabetes management. Semaglutide, …